Bevacizumab With or Without Fosbretabulin Tromethamine in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
51 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Saint Joseph'S Hospital and Medical Center
Phoenix, Arizona, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- John Muir Medical Center-Concord Campus
Concord, California, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Cedars Sinai Medical Center
Los Angeles, California, United States
- Sutter Medical Center Sacramento
Sacramento, California, United States
- Penrose-Saint Francis Healthcare
Colorado Springs, Colorado, United States
- Presbyterian - Saint Lukes Medical Center - Health One
Denver, Colorado, United States
- Scl Health Lutheran Medical Center
Wheat Ridge, Colorado, United States
- Hartford Hospital
Hartford, Connecticut, United States
- Beebe Medical Center
Lewes, Delaware, United States
- Christiana Care Health System-Christiana Hospital
Newark, Delaware, United States
- Mercy Hospital
Miami, Florida, United States
- Northeast Georgia Medical Center-Gainesville
Gainesville, Georgia, United States
- Memorial Health University Medical Center
Savannah, Georgia, United States
- Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- Sudarshan K Sharma Md Limited-Gynecologic Oncology
Hinsdale, Illinois, United States
- Indiana University/melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
- Saint Vincent Hospital and Health Care Center
Indianapolis, Indiana, United States
- University of Iowa/holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- Maine Medical Center-Bramhall Campus
Portland, Maine, United States
- Medstar Franklin Square Medical Center/weinberg Cancer Institute
Baltimore, Maryland, United States
- Sinai Hospital of Baltimore
Baltimore, Maryland, United States
- University of Massachusetts Memorial Health Care
Worcester, Massachusetts, United States
- University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- Borgess Medical Center
Kalamazoo, Michigan, United States
- Bronson Methodist Hospital
Kalamazoo, Michigan, United States
- West Michigan Cancer Center
Kalamazoo, Michigan, United States
- Saint Dominic-Jackson Memorial Hospital
Jackson, Mississippi, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Women'S Cancer Center of Nevada
Las Vegas, Nevada, United States
- Novant Health Presbyterian Medical Center
Charlotte, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Summa Akron City Hospital/cooper Cancer Center
Akron, Ohio, United States
- University of Cincinnati/barrett Cancer Center
Cincinnati, Ohio, United States
- Cleveland Clinic Cancer Center/fairview Hospital
Cleveland, Ohio, United States
- Hillcrest Hospital Cancer Center
Mayfield Heights, Ohio, United States
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Mar 2011
- Primary completion
- 20 Aug 2016
- Completion
- 3 Nov 2016
- Last update posted
- 30 Jul 2019
- Registered enrollment
- 107
- Registry id
- NCT01305213
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.